Autopsy report · NCT02414724

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma

“PI left institute”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 1 month before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Roswell Park Cancer Institute

Sponsor type

University, hospital or other

Conditions

Lymphoma; Solid Neoplasm

Interventions

Gemcitabine Hydrochloride; Laboratory Biomarker Analysis; Pharmacological Study; Ribociclib

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• H-coil TMS to Reduce Pain: A Pilot Study Evaluating Relative Efficacy of the H1 vs H7 Coil
  “PI left institution” (86% match in meaning)
• Right-sided Retroflexion With Standard Adult Versus Pediatric Colonoscopes
  “PI has left institution” (82% match in meaning)
• Cilostazol After Lower Extremity Arterial Revascularization Trial
  “Original PI left institution” (81% match in meaning)
• Pulse Wave Analysis in Advanced Heart Failure
  “PI left University” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.